Skip to main content

Medical Subject Headings (thesaurus)

Search from vocabulary

align
annotate
download

Concept information

Nucleic Acids, Nucleotides, and Nucleosides > Nucleosides > Arabinonucleosides > Clofarabine
Carbohydrates > Glycosides > Nucleosides > Arabinonucleosides > Clofarabine
Nucleic Acids, Nucleotides, and Nucleosides > Nucleotides > Ribonucleotides > Adenine Nucleotides > Clofarabine
... > Carbohydrates > Glycosides > Nucleotides > Ribonucleotides > Adenine Nucleotides > Clofarabine
... > Heterocyclic Compounds > Heterocyclic Compounds, Fused-Ring > Heterocyclic Compounds, 2-Ring > Purines > Purine Nucleotides > Adenine Nucleotides > Clofarabine
Nucleic Acids, Nucleotides, and Nucleosides > Nucleotides > Purine Nucleotides > Adenine Nucleotides > Clofarabine
... > Carbohydrates > Glycosides > Nucleotides > Purine Nucleotides > Adenine Nucleotides > Clofarabine

Preferred term

Clofarabine  

Type

  • mesh:Descriptor

Definition

  • An adenine arabinonucleoside derivative that acts as an antineoplastic antimetabolite. It is used in the treatment of ACUTE LYMPHOID LEUKEMIA in pediatric patients who have relapsed.

Broader concept

Entry terms

  • 123318-82-1 (Clofarabine)
  • 2-Chloro-2'-arabino-fluoro-2'-deoxyadenosine
  • 2-Chloro-2'-fluoroarabino-2'-deoxyadenosine
  • 2-Chloro-9-(2-deoxy-2-fluoroarabinofuranosyl)adenine
  • 2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arbinofuranosyl)adenine
  • 762RDY0Y2H
  • 9H-Purin-6-amine, 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-
  • Cl-F-ara-A

Allowable Qualifier(s)

Pharmacological Action(s)

In other languages

  • Clofarabine

    French

  • 123318-82-1 (Clofarabine)
  • 2-Chloro-2'-arabino-fluoro-2'-déoxyadénosine
  • 2-Chloro-2'-fluoroarabino-2'-déoxyadénosine
  • 2-Chloro-9-(2-déoxy-2-fluoro-bêta-D-arbinofuranosyl)adénine
  • 2-Chloro-9-(2-déoxy-2-fluoroarabinofuranosyl)adénine
  • 762RDY0Y2H
  • Cl-F-ara-A

URI

http://data.loterre.fr/ark:/67375/JVR-Z5ZMVTX3-D

Download this concept:

RDF/XML TURTLE JSON-LD Created 7/9/18, last modified 4/29/19